Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis

Lissbeth Leon1, Jean-François Jeannin, Ali Bettaieb

  • 1EPHE, Laboratoire d'immunologie et immunothérapie des cancers, Inserm U866, Dijon, F-21000, France. leonlissbeth@yahoo.fr

Insights

Nitric oxide (NO) and reactive oxygen species (ROS) modifications impact cell death pathways. This review explores how NO protein modifications influence cancer cell survival and death.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Post-translational modifications (PTMs) are crucial for regulating protein function.
  • Nitric oxide (NO) and reactive oxygen species (ROS) are key signaling molecules involved in cellular processes.
  • PTMs induced by NO and ROS are increasingly implicated in cell death regulation.

Purpose of the Study:

  • To review the current understanding of nitric oxide (NO)-induced protein modifications.
  • To elucidate the dual role of NO modifications in promoting or inhibiting cell death.
  • To focus on the significance of these modifications in cancer cells.

Main Methods:

  • Literature review of existing research on NO, ROS, PTMs, and cell death.
  • Analysis of studies investigating specific NO-protein interactions and their functional outcomes.
  • Synthesis of data focusing on cancer cell models.

Main Results:

  • NO can induce various PTMs, including S-nitrosylation, tyrosine nitration, and S-glutathionylation.
  • These NO-induced PTMs can modulate the activity of proteins involved in apoptosis, autophagy, and necrosis.
  • Evidence suggests NO modifications can both promote and inhibit cancer cell death depending on context.

Conclusions:

  • NO-mediated PTMs represent a critical regulatory mechanism in cell death pathways.
  • Targeting NO-protein interactions offers potential therapeutic strategies for cancer treatment.
  • Further research is needed to fully delineate the complex roles of NO modifications in cancer biology.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...